AlgoDx, which focuses on supporting disease prediction with machine learning algorithms, has announced the obtention of regulatory approval from the Swedish Medical Products Agency (MPA) to start a sepsis prediction study at an Intensive Care Unit (ICU) in Sweden. The study has previously been apAlready a subscriber Login You have…